Ropes & Gray advised ELIQUENT Life Sciences and GHO Capital, in its strategic acquisition of Truliant Consulting, a pharmacovigilance, risk management, and regulatory compliance advisory firm. The integration of Truliant’s specialized knowledge and technology-driven service offerings expands ELIQUENT’s pharmacovigilance platform. The transaction was announced in a April 2 press release.
ELIQUENT Life Sciences is a leading global consulting group delivering regulatory affairs, pharmacovigilance, quality and compliance solutions that support clients across therapeutic modalities, phase-based pathways and major global markets. ELIQUENT’s continued growth is supported by GHO Capital, the European specialist investor in healthcare.
The Ropes & Gray team included private equity partners Andrew Pomranke, Tim Castelli and Shona Ha, tax partner Elaine Murphy, employment partner Jen Cormier, healthcare partner Jennifer Romig, and life sciences regulatory & compliance partner Josh Oyster.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.